Helsinn and Eisai link up for combination anti-emetic in the US
This article was originally published in Scrip
Executive Summary
Helsinn Healthcare has joined forces with Eisai's US subsidiary to develop and commercialise in the US a combination product for the prevention of chemotherapy-induced nausea and vomiting (CINV).